10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANIX (Anixa) Stock Analysis
Buy, Hold or Sell?

Let's analyze Anixa together

I guess you are interested in Anixa Biosciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Anixa’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Anixa’s Price Targets

I'm going to help you getting a better view of Anixa Biosciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Anixa Biosciences Inc

I send you an email if I find something interesting about Anixa Biosciences Inc.

1. Quick Overview

1.1. Quick analysis of Anixa (30 sec.)










1.2. What can you expect buying and holding a share of Anixa? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$0.46
Expected worth in 1 year
$0.22
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$-0.24
Return On Investment
-7.6%

For what price can you sell your share?

Current Price per Share
$3.14
Expected price per share
$2.331 - $4.0954
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Anixa (5 min.)




Live pricePrice per Share (EOD)
$3.14
Intrinsic Value Per Share
$-1.51 - $-0.04
Total Value Per Share
$-1.05 - $0.43

2.2. Growth of Anixa (5 min.)




Is Anixa growing?

Current yearPrevious yearGrowGrow %
How rich?$14.9m$23.5m-$5.7m-32.2%

How much money is Anixa making?

Current yearPrevious yearGrowGrow %
Making money-$3m-$2.8m-$134.7k-4.4%
Net Profit Margin0.0%-431.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Anixa (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#536 / 872

Most Revenue
#827 / 872

Most Profit
#345 / 872

Most Efficient
#207 / 872
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Anixa?

Welcome investor! Anixa's management wants to use your money to grow the business. In return you get a share of Anixa.

First you should know what it really means to hold a share of Anixa. And how you can make/lose money.

Speculation

The Price per Share of Anixa is $3.14. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Anixa.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Anixa, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.46. Based on the TTM, the Book Value Change Per Share is $-0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.03 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Anixa.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.09-2.8%-0.09-3.0%-0.09-2.9%-0.09-2.8%-0.09-2.9%-0.08-2.6%
Usd Book Value Change Per Share-0.06-1.8%-0.06-1.9%-0.03-0.8%-0.04-1.4%0.020.5%0.010.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-1.8%-0.06-1.9%-0.03-0.8%-0.04-1.4%0.020.5%0.010.2%
Usd Price Per Share2.79-3.13-3.57-3.72-3.69-3.63-
Price to Earnings Ratio-8.05--8.33--9.96--10.56--10.24--10.08-
Price-to-Total Gains Ratio-49.73--52.95-90.80--33.45--10.22--123.55-
Price to Book Ratio6.03-5.69-4.87-5.24-5.50-17.55-
Price-to-Total Gains Ratio-49.73--52.95-90.80--33.45--10.22--123.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.14
Number of shares318
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.02
Usd Total Gains Per Share-0.060.02
Gains per Quarter (318 shares)-18.944.98
Gains per Year (318 shares)-75.7719.91
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-76-8602010
20-152-16204030
30-227-23806050
40-303-31408070
50-379-390010090
60-455-4660119110
70-530-5420139130
80-606-6180159150
90-682-6940179170
100-758-7700199190

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%5.0137.00.03.5%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%11.029.00.027.5%48.088.06.033.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%7.00.0135.04.9%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%11.029.00.027.5%48.088.06.033.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Anixa Biosciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.056-0.060+6%-0.026-54%-0.043-24%0.016-458%0.006-1013%
Book Value Per Share--0.4630.553-16%0.731-37%0.717-35%0.744-38%0.440+5%
Current Ratio--8.8859.522-7%14.079-37%14.324-38%16.480-46%10.958-19%
Debt To Asset Ratio--0.1220.115+6%0.075+62%0.083+47%0.078+56%0.250-51%
Debt To Equity Ratio--0.1290.122+5%0.078+64%0.087+48%0.082+56%0.443-71%
Dividend Per Share----0%-0%-0%-0%0.000-100%
Enterprise Value--103394969.000116824465.250-11%137014821.500-25%141617190.167-27%141714118.200-27%129925036.947-20%
Eps---0.087-0.094+9%-0.090+4%-0.089+3%-0.093+7%-0.082-5%
Ev To Ebitda Ratio---8.634-8.921+3%-10.933+27%-11.634+35%-11.637+35%-15.172+76%
Free Cash Flow Per Share---0.047-0.062+33%-0.056+19%-0.054+16%-0.050+7%-0.042-11%
Free Cash Flow To Equity Per Share---0.046-0.060+30%-0.029-37%-0.043-6%0.064-172%0.031-249%
Gross Profit Margin--1.0001.0000%1.0020%1.0010%1.0000%1.0000%
Intrinsic Value_10Y_max---0.036----------
Intrinsic Value_10Y_min---1.511----------
Intrinsic Value_1Y_max---0.143----------
Intrinsic Value_1Y_min---0.207----------
Intrinsic Value_3Y_max---0.324----------
Intrinsic Value_3Y_min---0.577----------
Intrinsic Value_5Y_max---0.376----------
Intrinsic Value_5Y_min---0.896----------
Market Cap101142854.000+11%89868969.000100740215.250-11%114832571.500-22%119771606.833-25%118714009.050-24%117079215.197-23%
Net Profit Margin----0%-4.3110%-2.2450%-0.7240%-1.0980%
Operating Margin----0%-4.3610%-2.4740%-0.8570%-1.0980%
Operating Ratio----0%4.909-100%2.736-100%1.019-100%1.258-100%
Pb Ratio6.785+11%6.0295.689+6%4.873+24%5.242+15%5.504+10%17.552-66%
Pe Ratio-9.063-13%-8.053-8.330+3%-9.956+24%-10.565+31%-10.237+27%-10.082+25%
Price Per Share3.140+11%2.7903.128-11%3.565-22%3.718-25%3.686-24%3.635-23%
Price To Free Cash Flow Ratio-16.823-13%-14.948-15.877+6%-16.298+9%-19.779+32%-20.812+39%-26.106+75%
Price To Total Gains Ratio-55.973-13%-49.734-52.948+6%90.799-155%-33.447-33%-10.224-79%-123.546+148%
Quick Ratio--15.51917.013-9%26.162-41%24.263-36%23.972-35%15.677-1%
Return On Assets---0.164-0.152-7%-0.114-30%-0.117-29%-0.129-22%-0.224+36%
Return On Equity---0.174-0.162-7%-0.119-32%-0.123-29%-0.135-22%-0.294+69%
Total Gains Per Share---0.056-0.060+6%-0.026-54%-0.043-24%0.016-458%0.007-959%
Usd Book Value--14906000.00017799500.000-16%23535250.000-37%23105916.667-35%23953805.350-38%14182056.975+5%
Usd Book Value Change Per Share---0.056-0.060+6%-0.026-54%-0.043-24%0.016-458%0.006-1013%
Usd Book Value Per Share--0.4630.553-16%0.731-37%0.717-35%0.744-38%0.440+5%
Usd Dividend Per Share----0%-0%-0%-0%0.000-100%
Usd Enterprise Value--103394969.000116824465.250-11%137014821.500-25%141617190.167-27%141714118.200-27%129925036.947-20%
Usd Eps---0.087-0.094+9%-0.090+4%-0.089+3%-0.093+7%-0.082-5%
Usd Free Cash Flow---1503000.000-1994250.000+33%-1794750.000+19%-1745000.000+16%-1612228.200+7%-1340043.450-11%
Usd Free Cash Flow Per Share---0.047-0.062+33%-0.056+19%-0.054+16%-0.050+7%-0.042-11%
Usd Free Cash Flow To Equity Per Share---0.046-0.060+30%-0.029-37%-0.043-6%0.064-172%0.031-249%
Usd Market Cap101142854.000+11%89868969.000100740215.250-11%114832571.500-22%119771606.833-25%118714009.050-24%117079215.197-23%
Usd Price Per Share3.140+11%2.7903.128-11%3.565-22%3.718-25%3.686-24%3.635-23%
Usd Profit---2790000.000-3033500.000+9%-2898750.000+4%-2831833.333+1%-2954655.950+6%-2572221.125-8%
Usd Revenue----0%39000.000-100%205780500.000-100%123668382.000-100%61602200.550-100%
Usd Total Gains Per Share---0.056-0.060+6%-0.026-54%-0.043-24%0.016-458%0.007-959%
 EOD+5 -3MRQTTM+15 -18YOY+9 -263Y+9 -265Y+9 -2610Y+12 -25

3.3 Fundamental Score

Let's check the fundamental score of Anixa Biosciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-9.063
Price to Book Ratio (EOD)Between0-16.785
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than115.519
Current Ratio (MRQ)Greater than18.885
Debt to Asset Ratio (MRQ)Less than10.122
Debt to Equity Ratio (MRQ)Less than10.129
Return on Equity (MRQ)Greater than0.15-0.174
Return on Assets (MRQ)Greater than0.05-0.164
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Anixa Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.317
Ma 20Greater thanMa 503.338
Ma 50Greater thanMa 1002.981
Ma 100Greater thanMa 2002.920
OpenGreater thanClose3.120
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Anixa Biosciences Inc

Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology. Its therapeutics programs include the development of a chimeric endocrine receptor-T cell therapy, a novel form of chimeric antigen receptor-T cell (CAR-T) technology that is focused on treating ovarian cancer. The company's vaccine programs include the development of a vaccine against breast cancer, initially focused on triple negative breast cancer (TNBC), the most lethal form of breast cancer; and the development of a vaccine against ovarian cancer, as well as a vaccine discovery program to develop additional cancer vaccines to address intractable cancers, including high incidence malignancies in lung, colon, and prostate. Its vaccine technologies focus on the discovery of additional retired proteins that may be associated with other forms of cancer. The company was formerly known as ITUS Corporation and changed its name to Anixa Biosciences, Inc. in October 2018. Anixa Biosciences, Inc. was incorporated in 1982 and is based in San Jose, California.

Fundamental data was last updated by Penke on 2025-07-10 20:46:06.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Anixa earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A Net Profit Margin of 0.0%Β means thatΒ $0.00 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Anixa Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-431.1%+431.1%
TTM-5Y-72.4%+72.4%
5Y-72.4%10Y-109.8%+37.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--93.6%+93.6%
TTM--140.9%+140.9%
YOY-431.1%-197.6%-233.5%
3Y-224.5%-248.5%+24.0%
5Y-72.4%-343.4%+271.0%
10Y-109.8%-496.2%+386.4%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Anixa is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • -16.4% Return on Assets means thatΒ Anixa generatedΒ $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Anixa Biosciences Inc:

  • The MRQ is -16.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -15.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-16.4%TTM-15.2%-1.2%
TTM-15.2%YOY-11.4%-3.8%
TTM-15.2%5Y-12.9%-2.4%
5Y-12.9%10Y-22.4%+9.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-16.4%-11.6%-4.8%
TTM-15.2%-11.6%-3.6%
YOY-11.4%-11.4%0.0%
3Y-11.7%-11.8%+0.1%
5Y-12.9%-12.0%-0.9%
10Y-22.4%-13.7%-8.7%
4.3.1.3. Return on Equity

Shows how efficient Anixa is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • -17.4% Return on Equity means Anixa generated $-0.17Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Anixa Biosciences Inc:

  • The MRQ is -17.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.4%TTM-16.2%-1.2%
TTM-16.2%YOY-11.9%-4.3%
TTM-16.2%5Y-13.5%-2.6%
5Y-13.5%10Y-29.4%+15.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.4%-13.5%-3.9%
TTM-16.2%-14.9%-1.3%
YOY-11.9%-14.6%+2.7%
3Y-12.3%-16.8%+4.5%
5Y-13.5%-17.5%+4.0%
10Y-29.4%-19.9%-9.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Anixa Biosciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Anixa is operatingΒ .

  • Measures how much profit Anixa makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Anixa to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Anixa Biosciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-436.1%+436.1%
TTM-5Y-85.7%+85.7%
5Y-85.7%10Y-109.8%+24.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--232.5%+232.5%
TTM--250.5%+250.5%
YOY-436.1%-209.2%-226.9%
3Y-247.4%-234.1%-13.3%
5Y-85.7%-346.1%+260.4%
10Y-109.8%-477.5%+367.7%
4.3.2.2. Operating Ratio

Measures how efficient Anixa is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY4.909-4.909
TTM-5Y1.019-1.019
5Y1.01910Y1.258-0.238
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.111-2.111
TTM-2.694-2.694
YOY4.9093.096+1.813
3Y2.7363.652-0.916
5Y1.0194.745-3.726
10Y1.2586.614-5.356
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Anixa Biosciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Anixa is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 8.89Β means the company has $8.89 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 8.885. The company is very able to pay all its short-term debts. +2
  • The TTM is 9.522. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.885TTM9.522-0.637
TTM9.522YOY14.079-4.557
TTM9.5225Y16.480-6.958
5Y16.48010Y10.958+5.522
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.8853.661+5.224
TTM9.5223.846+5.676
YOY14.0794.140+9.939
3Y14.3244.688+9.636
5Y16.4805.746+10.734
10Y10.9586.147+4.811
4.4.3.2. Quick Ratio

Measures if Anixa is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A Quick Ratio of 15.52Β means the company can pay off $15.52 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 15.519. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 17.013. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ15.519TTM17.013-1.494
TTM17.013YOY26.162-9.149
TTM17.0135Y23.972-6.959
5Y23.97210Y15.677+8.295
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ15.5192.848+12.671
TTM17.0133.169+13.844
YOY26.1623.786+22.376
3Y24.2634.311+19.952
5Y23.9725.703+18.269
10Y15.6776.368+9.309
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Anixa Biosciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of AnixaΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Anixa to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.12Β means that Anixa assets areΒ financed with 12.2% credit (debt) and the remaining percentage (100% - 12.2%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.122. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.115. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.122TTM0.115+0.007
TTM0.115YOY0.075+0.040
TTM0.1155Y0.078+0.037
5Y0.07810Y0.250-0.171
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1220.329-0.207
TTM0.1150.349-0.234
YOY0.0750.331-0.256
3Y0.0830.340-0.257
5Y0.0780.349-0.271
10Y0.2500.379-0.129
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Anixa is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 12.9% means that company has $0.13 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Anixa Biosciences Inc:

  • The MRQ is 0.129. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.122. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.129TTM0.122+0.007
TTM0.122YOY0.078+0.044
TTM0.1225Y0.082+0.040
5Y0.08210Y0.443-0.361
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1290.379-0.250
TTM0.1220.437-0.315
YOY0.0780.414-0.336
3Y0.0870.450-0.363
5Y0.0820.464-0.382
10Y0.4430.515-0.072
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Anixa generates.

  • Above 15 is considered overpriced butΒ always compareΒ Anixa to theΒ Biotechnology industry mean.
  • A PE ratio of -8.05 means the investor is paying $-8.05Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Anixa Biosciences Inc:

  • The EOD is -9.063. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.053. Based on the earnings, the company is expensive. -2
  • The TTM is -8.330. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.063MRQ-8.053-1.010
MRQ-8.053TTM-8.330+0.278
TTM-8.330YOY-9.956+1.626
TTM-8.3305Y-10.237+1.906
5Y-10.23710Y-10.082-0.155
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-9.063-2.356-6.707
MRQ-8.053-2.077-5.976
TTM-8.330-2.574-5.756
YOY-9.956-3.760-6.196
3Y-10.565-3.773-6.792
5Y-10.237-6.193-4.044
10Y-10.082-6.876-3.206
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Anixa Biosciences Inc:

  • The EOD is -16.823. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.948. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.877. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-16.823MRQ-14.948-1.875
MRQ-14.948TTM-15.877+0.929
TTM-15.877YOY-16.298+0.420
TTM-15.8775Y-20.812+4.934
5Y-20.81210Y-26.106+5.294
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-16.823-3.246-13.577
MRQ-14.948-2.705-12.243
TTM-15.877-3.704-12.173
YOY-16.298-4.402-11.896
3Y-19.779-5.070-14.709
5Y-20.812-8.477-12.335
10Y-26.106-9.305-16.801
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Anixa is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 6.03 means the investor is paying $6.03Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Anixa Biosciences Inc:

  • The EOD is 6.785. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.029. Based on the equity, the company is overpriced. -1
  • The TTM is 5.689. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD6.785MRQ6.029+0.756
MRQ6.029TTM5.689+0.340
TTM5.689YOY4.873+0.816
TTM5.6895Y5.504+0.185
5Y5.50410Y17.552-12.049
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.7852.038+4.747
MRQ6.0291.843+4.186
TTM5.6892.125+3.564
YOY4.8732.442+2.431
3Y5.2422.492+2.750
5Y5.5043.652+1.852
10Y17.5524.311+13.241
4.6.2. Total Gains per Share

2.4. Latest News of Anixa Biosciences Inc

Does Anixa Biosciences Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Anixa Biosciences Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-07-09
14:05
Anixa Biosciences to receive new US patent for ovarian cancer vaccineRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Anixa Biosciences Inc.

4.8.1. Institutions holding Anixa Biosciences Inc

Institutions are holding 17.604% of the shares of Anixa Biosciences Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-03-31Vanguard Group Inc4.32430.0001139290600
2025-03-31Laird Norton Tyee Trust Co1.93170.286362223500
2025-03-31Davidson D A & Co1.9070.0141614272-56800-8.4641
2025-03-31UBS Group AG1.62730.0003524162-9962-1.8651
2025-03-31Mission Wealth Management, LLC1.45760.03346951700
2025-03-31Geode Capital Management, LLC1.05640.0001340265108883.3056
2025-03-31Bank of America Corp0.65280.0001210269120.0057
2025-03-31BlackRock Inc0.60670195423123916.7699
2025-03-31Susquehanna International Group, LLP0.60590.0001195171-86522-30.715
2025-03-31State Street Corp0.3741012050000
2025-03-31GSA Capital Partners LLP0.23530.019675804758040
2025-03-31The Colony Group LLC0.22290.000571802-68198-48.7129
2025-03-31Northern Trust Corp0.20706668200
2025-03-31Bank of New York Mellon Corp0.1824058745-1-0.0017
2025-03-31LPL Financial Corp0.17680.0001569371400032.6059
2025-03-31Kestra Advisory Services, LLC0.14280.0006460001800064.2857
2025-03-31CoreCap Advisors, LLC0.1390.00564478700
2025-03-31Tyler-Stone Wealth Management0.13040.02164201600
2025-03-31CI Private Wealth LLC0.11610.00023740000
2025-03-31Westside Investment Management, Inc.0.10870.02133500000
Total 16.20520.40365219893-90388-1.7%

4.9.2. Funds holding Anixa Biosciences Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-05-31Vanguard Total Stock Mkt Idx Inv2.88050.000192784100
2025-05-31Vanguard Institutional Extnd Mkt Idx Tr1.30590.00142065800
2025-04-30Fidelity Extended Market Index0.52030.0013167581-1602-0.9469
2025-03-31Extended Equity Market Fund K0.22390.0016721302210.3073
2025-05-31iShares Micro-Cap ETF0.19080.02046145100
2025-04-30Fidelity Total Market Index0.16540.00025327700
2025-04-30Fidelity Series Total Market Index0.13320.00024291815213.6742
2025-03-31Northern Trust Extended Eq Market Idx0.10760.00133467400
2025-03-31NT Ext Equity Mkt Idx Fd - L0.10760.00133467400
2025-04-30Spartan Extended Market Index Pool F0.10730.00133457816024.8581
2025-03-31NT Ext Equity Mkt Idx Fd - NL0.0960.00153093200
2025-04-30Fidelity Nasdaq Composite Index0.07480.00042410200
2025-03-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.07480.001524078-438-1.7866
2024-12-31Vanguard Instl Ttl Stck Mkt Idx Tr0.06540.00022107900
2025-05-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.06540.00022107900
2025-04-30Spartan Total Market Index Pool G0.05840.00011880412216.9442
2025-05-31Schwab Total Stock Market Index0.03970.00011278500
2025-05-31Vanguard Balanced Index Inv0.03910.00011259900
2025-05-31Vanguard U.S. Eq Idx Β£ Acc0.03330.00011072900
2025-03-31Extended Equity Market Fund M0.0280.00169034-307-3.2866
Total 6.31740.03452035003+2218+0.1%

5.3. Insider Transactions

Insiders are holding 5.321% of the shares of Anixa Biosciences Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-04Amit KumarBUY100002.85
2025-01-28Arnold M BaskiesBUY50002.82
2025-01-23Lewis H Titterton JrBUY20002.91
2025-01-21Lewis H Titterton JrBUY60002.59
2025-01-17Lewis H Titterton JrBUY100002.57
2025-01-15Amit KumarBUY430002.23
2025-01-15Michael CatelaniBUY92892.15
2024-07-30Lewis H Titterton JrBUY216463.06
2024-07-26Arnold M BaskiesBUY50003.09
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-04-30. Currency in USD. All numbers in thousands.

Summary
Total Assets16,977
Total Liabilities2,071
Total Stockholder Equity16,068
 As reported
Total Liabilities 2,071
Total Stockholder Equity+ 16,068
Total Assets = 16,977

Assets

Total Assets16,977
Total Current Assets16,766
Long-term Assets211
Total Current Assets
Cash And Cash Equivalents 1,910
Short-term Investments 13,687
Other Current Assets 1,169
Total Current Assets  (as reported)16,766
Total Current Assets  (calculated)16,766
+/-0
Long-term Assets
Property Plant Equipment 211
Long-term Assets  (as reported)211
Long-term Assets  (calculated)211
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,887
Long-term Liabilities184
Total Stockholder Equity16,068
Total Current Liabilities
Short-term Debt 37
Accounts payable 284
Other Current Liabilities 1,566
Total Current Liabilities  (as reported)1,887
Total Current Liabilities  (calculated)1,887
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt184
Long-term Liabilities  (as reported)184
Long-term Liabilities  (calculated)184
+/-0
Total Stockholder Equity
Common Stock322
Retained Earnings -246,724
Other Stockholders Equity 262,470
Total Stockholder Equity (as reported)16,068
Total Stockholder Equity (calculated)16,068
+/-0
Other
Capital Stock322
Cash and Short Term Investments 15,597
Common Stock Shares Outstanding 32,202
Liabilities and Stockholders Equity 16,977
Net Debt -1,689
Net Invested Capital 16,068
Net Working Capital 14,879
Property Plant and Equipment Gross 211
Short Long Term Debt Total 221



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-04-302025-01-312024-10-312024-07-312024-04-302024-01-312023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-12-012017-10-312017-07-312017-04-302017-01-312016-10-312016-07-312016-04-302016-01-312015-10-312015-07-312015-04-302015-01-312014-10-312014-07-312014-04-302014-01-312013-10-312013-07-312013-04-302013-01-312012-10-312012-07-312012-04-302012-01-312011-10-312011-07-312011-04-302011-01-312010-10-312010-07-312010-04-302010-01-312009-10-312009-07-312009-04-302009-01-312008-10-312008-07-312008-04-302008-01-312007-10-312007-07-312007-04-302007-01-312006-10-312006-07-312006-04-302006-01-312005-10-312005-07-312005-04-302005-01-312004-10-312004-07-312004-04-302004-01-312003-10-312003-07-312003-04-302003-01-312002-10-312002-07-312002-04-302002-01-312001-10-312001-07-312001-04-302001-01-312000-10-312000-07-312000-04-302000-01-311999-10-311999-07-311999-04-301999-01-311998-10-311998-07-311998-04-301998-01-311997-10-311997-07-311997-04-301997-01-311996-10-311996-07-311996-04-301996-01-311995-10-311995-07-311995-04-301995-01-311994-10-311994-07-311994-04-301994-01-311993-10-311993-07-311993-04-301993-01-311992-10-311992-07-311992-04-301992-01-311991-10-311991-07-311991-04-301991-01-311990-10-311990-07-311990-04-301990-01-311989-10-311989-07-311989-04-301989-01-311988-10-311988-07-311988-04-301988-01-311987-10-311987-07-311987-04-301987-01-311986-10-311986-07-311986-04-301986-01-311985-10-31
> Total Assets 
3,300
0
0
0
1,500
0
0
0
1,200
0
0
0
2,100
0
0
0
4,200
4,200
4,200
4,200
4,200
4,300
4,200
4,200
4,300
4,500
4,500
4,300
4,400
5,700
6,000
7,900
8,700
7,700
7,200
7,400
6,600
6,000
7,200
9,400
9,700
11,500
15,400
23,400
24,700
23,100
22,500
21,400
20,000
18,300
16,300
15,000
13,300
12,700
11,700
10,500
8,100
8,100
9,740
9,302
6,895
6,302
5,771
7,542
6,562
8,737
7,381
3,575
2,732
2,430
1,826
2,331
2,330
2,131
2,516
2,281
2,316
2,347
2,068
1,756
1,466
1,646
1,696
1,601
1,864
2,048
1,977
1,820
1,870
24,283
21,204
14,624
7,498
6,054
6,008
8,077
9,848
9,711
10,175
8,625
10,046
8,262
8,627
10,169
8,646
8,029
6,794
5,887
5,661
7,522
7,354
5,308
5,440
10,327
10,500
13,399
9,055
13,270
11,133
10,279
9,336
8,647
7,206
6,321
5,628
4,219
7,249
8,415
8,812
8,812,416
7,491
7,361
7,294
6,449
6,470
7,765
6,843
6,294
6,164
5,925
9,362
9,453
14,604
38,498
37,062
36,257
35,238
32,797
32,563
30,412
28,306
27,599
26,578
25,522
25,372
24,355
22,908
21,591
18,906
16,977
16,97718,90621,59122,90824,35525,37225,52226,57827,59928,30630,41232,56332,79735,23836,25737,06238,49814,6049,4539,3625,9256,1646,2946,8437,7656,4706,4497,2947,3617,4918,812,4168,8128,4157,2494,2195,6286,3217,2068,6479,33610,27911,13313,2709,05513,39910,50010,3275,4405,3087,3547,5225,6615,8876,7948,0298,64610,1698,6278,26210,0468,62510,1759,7119,8488,0776,0086,0547,49814,62421,20424,2831,8701,8201,9772,0481,8641,6011,6961,6461,4661,7562,0682,3472,3162,2812,5162,1312,3302,3311,8262,4302,7323,5757,3818,7376,5627,5425,7716,3026,8959,3029,7408,1008,10010,50011,70012,70013,30015,00016,30018,30020,00021,40022,50023,10024,70023,40015,40011,5009,7009,4007,2006,0006,6007,4007,2007,7008,7007,9006,0005,7004,4004,3004,5004,5004,3004,2004,2004,3004,2004,2004,2004,2004,2000002,1000001,2000001,5000003,300
   > Total Current Assets 
3,000
0
0
0
1,100
0
0
0
700
0
0
0
1,900
0
0
0
4,000
4,000
4,100
4,000
4,000
4,100
4,000
4,100
4,200
4,300
4,300
4,100
4,200
5,500
5,800
7,600
8,400
7,400
6,800
7,100
6,300
5,700
6,900
8,800
9,000
10,300
14,000
21,500
22,600
21,000
20,600
19,600
18,200
16,700
14,800
13,700
9,000
8,600
7,700
7,200
7,500
7,600
9,310
8,952
3,655
3,121
2,641
4,549
3,580
5,753
4,445
3,480
2,654
2,363
1,768
2,280
2,285
2,089
2,476
2,241
2,272
2,305
2,029
1,720
1,434
1,611
1,566
1,364
1,623
1,597
1,524
1,368
1,416
1,553
1,622
2,316
2,257
2,831
2,386
2,179
2,396
2,122
1,974
1,528
1,235
1,088
1,785
3,644
3,120
2,610
1,788
1,145
922
1,780
1,326
1,029
1,234
3,367
3,630
6,435
6,322
10,571
8,523
7,754
6,896
6,187
4,801
4,006
3,400
2,069
5,192
6,446
7,014
7,013,940
5,775
5,721
5,720
5,538
6,236
7,494
6,628
6,093
5,869
5,657
9,264
9,369
14,564
38,472
37,052
36,003
34,994
32,563
32,340
30,200
28,105
27,410
26,400
25,356
25,219
24,214
22,670
21,362
18,686
16,766
16,76618,68621,36222,67024,21425,21925,35626,40027,41028,10530,20032,34032,56334,99436,00337,05238,47214,5649,3699,2645,6575,8696,0936,6287,4946,2365,5385,7205,7215,7757,013,9407,0146,4465,1922,0693,4004,0064,8016,1876,8967,7548,52310,5716,3226,4353,6303,3671,2341,0291,3261,7809221,1451,7882,6103,1203,6441,7851,0881,2351,5281,9742,1222,3962,1792,3862,8312,2572,3161,6221,5531,4161,3681,5241,5971,6231,3641,5661,6111,4341,7202,0292,3052,2722,2412,4762,0892,2852,2801,7682,3632,6543,4804,4455,7533,5804,5492,6413,1213,6558,9529,3107,6007,5007,2007,7008,6009,00013,70014,80016,70018,20019,60020,60021,00022,60021,50014,00010,3009,0008,8006,9005,7006,3007,1006,8007,4008,4007,6005,8005,5004,2004,1004,3004,3004,2004,1004,0004,1004,0004,0004,1004,0004,0000001,9000007000001,1000003,000
       Cash And Cash Equivalents 
2,800
0
0
0
1,000
0
0
0
700
0
0
0
1,700
0
0
0
2,200
2,500
1,700
2,200
2,100
2,100
3,000
2,100
4,100
4,300
4,300
4,100
4,100
5,400
5,800
7,600
8,300
7,400
6,800
7,000
6,200
5,700
6,900
8,700
8,900
10,200
13,900
21,400
22,200
19,500
18,500
15,800
12,300
11,200
8,000
6,100
5,400
4,400
3,700
2,300
1,600
2,100
3,589
2,621
1,134
703
158
2,016
1,317
3,455
2,142
1,302
855
603
408
1,057
1,024
868
1,243
1,040
1,003
1,012
641
582
507
809
732
611
1,282
828
766
653
669
794
764
458
479
1,716
1,291
321
1,451
1,197
1,075
1,409
1,094
979
347
551
774
463
131
102
340
1,713
1,274
982
898
776
618
3,652
3,361
7,810
6,080
5,161
4,369
3,981
2,612
2,049
2,488
1,400
2,877
1,834
3,339
3,339,374
2,847
4,172
2,591
3,056
4,153
3,822
4,397
3,492
2,822
2,888
5,928
6,417
11,983
27,703
27,222
29,128
29,781
27,732
24,254
12,360
9,790
5,620
3,198
915
998
995
1,225
1,271
1,053
1,910
1,9101,0531,2711,2259959989153,1985,6209,79012,36024,25427,73229,78129,12827,22227,70311,9836,4175,9282,8882,8223,4924,3973,8224,1533,0562,5914,1722,8473,339,3743,3391,8342,8771,4002,4882,0492,6123,9814,3695,1616,0807,8103,3613,6526187768989821,2741,7133401021314637745513479791,0941,4091,0751,1971,4513211,2911,7164794587647946696537668281,2826117328095075826411,0121,0031,0401,2438681,0241,0574086038551,3022,1423,4551,3172,0161587031,1342,6213,5892,1001,6002,3003,7004,4005,4006,1008,00011,20012,30015,80018,50019,50022,20021,40013,90010,2008,9008,7006,9005,7006,2007,0006,8007,4008,3007,6005,8005,4004,1004,1004,3004,3004,1002,1003,0002,1002,1002,2001,7002,5002,2000001,7000007000001,0000002,800
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
500
500
0
97
97
97
97
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
396
398
401
403
398
398
38
425
425
400
400
441
441
1,440
1,442
750
750
1,650
750
750
750
0
0
0
1,349
2,999
2,249
2,050
1,550
950
500
500
0
0
0
2,450
2,050
2,550
2,500
2,650
2,400
2,400
2,400
2,150
2,150
1,900
750
600
2,250
4,251
3,500
3,500,000
2,650
1,250
2,750
2,000
1,750
2,750
2,100
2,350
2,870
2,620
3,140
2,640
2,000
10,399
9,400
6,600
4,749
4,499
7,410
17,327
17,912
21,356
22,336
22,929
22,800
22,244
19,520
18,653
16,202
13,687
13,68716,20218,65319,52022,24422,80022,92922,33621,35617,91217,3277,4104,4994,7496,6009,40010,3992,0002,6403,1402,6202,8702,3502,1002,7501,7502,0002,7501,2502,6503,500,0003,5004,2512,2506007501,9002,1502,1502,4002,4002,4002,6502,5002,5502,0502,4500005005009501,5502,0502,2492,9991,3490007507507501,6507507501,4421,4404414414004004254253839839840340139839600000000000000009797979705005000000000000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
478
595
561
708
694
536
562
507
525
401
463
215
177
169
140
145
150
148
288
99
173
62
30
68
37
10
69
60
60
120
60
191
207
103
112
106
12
1
1
8
5
0
-141
0
0
0
0
0
0
0
0
0
0
175
175
828
133
400
45
0
0
0
0
0
0
0
0
0
221
0
0
0
0
0
307
0
797
1
67
22
32
6
2
0
0
0
0
0
0
0
46
147
256
334
270
391
218
410
173
0
0
00173410218391270334256147460000000263222671797030700000221000000000454001338281751750000000000-1410581112106112103207191601206060691037683062173992881481501451401691772154634015255075625366947085615954780000000000000000000000000000000000000000001,8000000000000000000
       Inventory 
100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
0
3,000
2,800
3,600
4,500
4,400
4,360
4,868
1,769
1,834
1,761
1,620
1,589
1,497
1,601
1,517
1,296
1,170
1,032
1,028
1,045
1,036
1,064
1,033
999
977
877
555
385
330
308
281
261
243
231
214
192
225
196
185
178
177
176
138
133
110
93
59
52
47
32
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-46
0
0
0
0
0
0
0
0
0
0
0000000000-460000000000000000000000000000000000000000000003332475259931101331381761771781851962251922142312432612813083303855558779779991,0331,0641,0361,0451,0281,0321,1701,2961,5171,6011,4971,5891,6201,7611,8341,7694,8684,3604,4004,5003,6002,8003,00001,80000000000000000000000000000000000000000000000000000100
       Other Current Assets 
100
0
0
0
100
0
0
0
0
0
0
0
200
0
0
0
0
1,500
2,400
1,800
1,900
2,000
1,000
2,000
100
0
0
0
100
100
0
0
100
0
0
100
100
0
0
100
100
100
100
100
400
1,500
2,100
3,800
5,900
5,500
6,800
5,800
3,600
1,200
1,200
800
900
1,100
1,264
888
60
23
14
219
137
239
194
137
103
128
113
17
48
45
23
18
122
27
17
12
481
38
60
36
32
32
42
41
35
33
30
26
54
77
63
58
124
65
48
56
89
62
57
61
97
97
107
93
82
67
104
95
161
141
134
101
61
66
43
194
127
56
39
113
162
137
129
281
175
0
278
596
757
175
667
249
259
185
309
233
380
312
1,163
738
860
552
928
664
676
513
256
178
532
1,242
1,030
757
1,515
1,265
1,431
1,169
1,1691,4311,2651,5157571,0301,2425321782565136766649285528607381,163312380233309185259249667175757596278017528112913716211339561271944366611011341411619510467829310797976157628956486512458637754263033354142323236603848112172712218234548171131281031371942391372191423608881,2641,1009008001,2001,2003,6005,8006,8005,5005,9003,8002,1001,5004001001001001001000010010000100001001000001002,0001,0002,0001,9001,8002,4001,50000002000000000100000100
   > Long-term Assets 
300
0
0
0
400
0
0
0
500
0
0
0
200
0
0
0
200
200
100
200
200
200
200
100
100
200
200
200
200
200
200
300
300
300
400
300
300
300
300
600
700
1,200
1,400
1,900
2,100
2,100
1,900
1,800
1,800
1,600
1,500
1,300
4,300
4,100
4,000
3,300
600
500
430
350
3,239
3,181
3,130
2,993
2,983
2,984
2,936
96
77
67
58
52
45
41
40
40
44
42
39
35
32
36
130
238
241
450
453
452
455
22,729
19,582
12,308
5,241
3,223
3,621
5,898
7,452
7,589
8,202
7,096
0
7,174
6,842
6,524
5,525
5,420
5,006
4,742
4,739
5,742
6,028
4,278
4,206
6,960
6,870
6,964
2,734
2,699
2,610
2,525
2,440
2,461
2,404
2,316
2,228
2,150
2,058
1,969
1,798
0
1,715
1,640
1,574
910
234
272
215
201
295
268
98
84
40
26
10
254
244
234
223
212
201
189
178
166
153
141
238
229
220
211
21122022923814115316617818920121222323424425410264084982682952012152722349101,5741,6401,71501,7981,9692,0582,1502,2282,3162,4042,4612,4402,5252,6102,6992,7346,9646,8706,9604,2064,2786,0285,7424,7394,7425,0065,4205,5256,5246,8427,17407,0968,2027,5897,4525,8983,6213,2235,24112,30819,58222,7294554524534502412381303632353942444040414552586777962,9362,9842,9832,9933,1303,1813,2393504305006003,3004,0004,1004,3001,3001,5001,6001,8001,8001,9002,1002,1001,9001,4001,200700600300300300300400300300300200200200200200200100100200200200200100200200000200000500000400000300
       Property Plant Equipment 
300
0
0
0
300
0
0
0
300
0
0
0
200
0
0
0
100
100
100
100
100
100
100
100
-500
100
-500
100
100
100
100
100
200
200
200
200
200
200
200
200
200
200
500
500
800
900
900
900
900
900
900
800
800
700
700
600
500
500
403
325
270
212
162
129
119
121
103
84
72
61
53
46
39
36
35
34
38
37
33
30
27
31
28
26
23
22
25
24
27
31
33
31
30
27
24
24
21
19
17
15
15
19
19
18
16
15
14
12
10
11
8
9
8
8
8
10
12
59
51
47
43
146
171
163
157
160
149
141
53
52,701
51
57
72
73
67
230
215
201
295
268
68
54
40
26
10
254
244
234
223
212
201
189
178
166
153
141
238
229
220
211
2112202292381411531661781892012122232342442541026405468268295201215230677372575152,701531411491601571631711464347515912108889811101214151618191915151719212424273031333127242522232628312730333738343536394653617284103121119129162212270325403500500600700700800800900900900900900900800500500200200200200200200200200200200100100100100100-500100-500100100100100100100100100000200000300000300000300
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,506
5,510
5,405
4,992
4,730
4,728
5,731
6,021
4,269
4,197
3,986
3,977
4,151
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000004,1513,9773,9864,1974,2696,0215,7314,7284,7304,9925,4055,5106,5060000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,966
2,884
2,803
2,722
2,640
2,559
2,478
2,396
2,315
2,234
2,152
2,071
1,990
1,908
1,827
1,746
0
1,664
1,583
1,502
838
168
42
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000421688381,5021,5831,66401,7461,8271,9081,9902,0712,1522,2342,3152,3962,4782,5592,6402,7222,8032,8842,96600000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
27
26
25
2,970
2,969
2,968
2,864
2,863
2,863
2,833
11
6
6
5
5
6
6
6
6
6
5
6
5
5
5
102
211
218
428
428
428
427
22,699
19,549
12,277
5,211
3,196
3,598
5,874
7,431
7,570
8,184
7,082
8,796
7,155
6,823
6,507
5,510
5,405
4,992
4,730
4,729
5,731
6,021
4,270
4,197
6,952
6,862
6,954
2,721
2,640
2,559
2,478
2,397
2,315
2,234
2,152
2,071
1,990
1,908
1,827
1,746
0
1,665
1,583
1,503
838
0
0
0
0
0
0
30
84
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000084300000008381,5031,5831,66501,7461,8271,9081,9902,0712,1522,2342,3152,3972,4782,5592,6402,7216,9546,8626,9524,1974,2706,0215,7314,7294,7304,9925,4055,5106,5076,8237,1558,7967,0828,1847,5707,4315,8743,5983,1965,21112,27719,54922,69942742842842821821110255565666665566112,8332,8632,8632,8642,9682,9692,970252627000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
100
100
100
100
100
100
100
100
200
200
200
300
300
400
300
500
600
400
300
200
300
300
200
300
500
500
800
1,900
1,500
1,300
1,500
1,200
1,300
1,100
1,400
1,400
1,400
1,300
1,600
1,800
2,000
2,075
2,335
1,337
1,269
1,147
3,202
2,396
4,114
1,535
394
414
462
421
390
342
383
408
360
443
422
293
270
348
472
372
292
582
367
328
320
679
5,587
5,483
6,594
5,768
5,680
5,456
5,212
5,396
5,391
5,389
5,492
5,450
5,583
5,552
7,927
7,588
7,291
7,133
6,780
6,855
8,846
8,800
8,545
8,760
15,997
15,346
13,250
5,046
5,013
4,143
4,282
4,282
5,056
4,646
4,603
4,641
8,037
3,660
2,927
889
8,812,416
1,087
1,340
1,129
1,265
1,327
1,596
1,444
1,481
1,166
1,103
1,224
1,189
1,525
1,443
1,208
1,491
1,996
1,391
1,656
2,212
1,394
1,686
1,993
2,151
1,768
1,774
2,217
2,703
2,193
2,071
2,0712,1932,7032,2171,7741,7682,1511,9931,6861,3942,2121,6561,3911,9961,4911,2081,4431,5251,1891,2241,1031,1661,4811,4441,5961,3271,2651,1291,3401,0878,812,4168892,9273,6608,0374,6414,6034,6465,0564,2824,2824,1435,0135,04613,25015,34615,9978,7608,5458,8008,8466,8556,7807,1337,2917,5887,9275,5525,5835,4505,4925,3895,3915,3965,2125,4565,6805,7686,5945,4835,5876793203283675822923724723482702934224433604083833423904214624143941,5354,1142,3963,2021,1471,2691,3372,3352,0752,0001,8001,6001,3001,4001,4001,4001,1001,3001,2001,5001,3001,5001,900800500500300200300300200300400600500300400300300200200200100100100100100100100100100000100000100000200000200
   > Total Current Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
100
100
100
100
100
200
100
200
200
200
200
300
200
400
300
400
600
400
300
200
300
300
200
200
400
600
700
2,000
1,500
1,400
1,500
1,200
1,300
1,100
1,400
1,500
1,400
1,300
1,600
1,800
2,000
2,075
2,335
1,337
1,269
1,147
3,202
2,396
4,114
1,535
394
414
462
421
390
342
383
408
360
443
422
293
270
348
472
372
292
582
367
328
320
679
587
483
1,594
768
680
456
212
396
391
389
492
450
583
552
2,927
2,105
2,055
2,133
1,780
1,822
3,439
3,301
3,095
3,212
11,548
10,682
8,357
1,810
1,667
689
712
594
1,244
707
532
469
3,724
3,660
2,927
889
889,493
1,087
1,340
1,129
1,265
1,327
1,596
1,444
1,481
1,126
1,077
1,213
1,189
1,525
1,443
1,208
1,271
1,787
1,189
1,469
2,037
1,232
1,537
1,857
2,028
1,660
1,681
2,004
2,500
1,999
1,887
1,8871,9992,5002,0041,6811,6602,0281,8571,5371,2322,0371,4691,1891,7871,2711,2081,4431,5251,1891,2131,0771,1261,4811,4441,5961,3271,2651,1291,3401,087889,4938892,9273,6603,7244695327071,2445947126891,6671,8108,35710,68211,5483,2123,0953,3013,4391,8221,7802,1332,0552,1052,9275525834504923893913962124566807681,5944835876793203283675822923724723482702934224433604083833423904214624143941,5354,1142,3963,2021,1471,2691,3372,3352,0752,0001,8001,6001,3001,4001,5001,4001,1001,3001,2001,5001,4001,5002,000700600400200200300300200300400600400300400200300200200200200100200100100100100100100000100000100000200000200
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
582
610
691
957
5,668
5,000
5,000
0
0
0
0
0
0
0
0
0
3,000
3,000
2,000
0
0
0
0
0
0
0
0
0
0
107
111
116
110
82
52
21
78
82
78
44
92
94
98
102
104
108
112
24
29
36
37
373629241121081041029894924478827821528211011611110700000000002,0003,0003,0000000000005,0005,0005,6689576916105820000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
100
100
100
200
200
200
300
200
400
300
400
600
400
300
200
200
300
200
200
400
500
700
2,000
1,500
1,400
1,500
1,200
1,300
1,100
1,400
1,400
1,200
1,200
1,300
1,500
1,700
1,949
2,167
1,036
1,045
940
815
816
548
410
341
379
411
380
353
317
334
374
323
403
398
252
231
271
404
313
253
533
318
199
244
347
403
424
308
385
470
294
104
326
315
304
390
356
431
456
278
375
449
559
463
305
489
534
516
527
492
458
529
540
578
389
425
162
560
418
445
373
541
448
445
480
0
417
452
419
582
613
718
568
586
367
171
339
232
512
438
208
136
504
93
227
265
110
195
94
206
364
215
302
525
600
284
284600525302215364206941951102652279350413620843851223233917136758656871861358241945241704804454485413734454185601624253895785405294584925275165344893054635594493752784564313563903043153261042944703853084244033472441993185332533134042712312523984033233743343173533804113793414105488168159401,0451,0362,1671,9491,7001,5001,3001,2001,2001,4001,4001,1001,3001,2001,5001,4001,5002,00070050040020020030020020030040060040030040020030020020020010010010010010010010010000000000000000000
       Other Current Liabilities 
200
0
0
0
200
0
0
0
100
0
0
0
100
0
0
0
100
0
0
0
0
0
100
0
100
0
0
0
0
0
0
0
0
0
0
0
0
100
0
0
0
0
100
0
0
0
0
0
0
0
0
0
100
200
100
300
300
300
126
168
301
224
206
220
38
57
41
53
35
51
42
37
25
49
34
37
40
24
41
39
77
68
59
39
49
49
129
76
332
184
59
56
69
210
161
108
70
76
86
103
94
152
96
75
86
162
140
130
331
1,762
1,580
1,391
1,497
4,201
4,037
2,828
1,269
1,090
300
287
432
684
289
87
96
183
212
482
409
0
670
888
710
683
714
878
876
895
652
794
758
846
932
953
979
1,056
1,201
1,018
1,198
1,680
1,028
1,244
1,661
1,718
1,188
1,354
1,654
1,946
1,363
1,566
1,5661,3631,9461,6541,3541,1881,7181,6611,2441,0281,6801,1981,0181,2011,056979953932846758794652895876878714683710888670040948221218396872896844322873001,0901,2692,8284,0374,2011,4971,3911,5801,7623311301401628675961529410386767010816121069565918433276129494939596877394124403734492537425135534157382202062243011681263003003001002001000000000001000000100000000000000100010000000100000100000100000200000200
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
100
100
100
100
100
-100
100
-100
200
200
200
300
100
400
300
100
600
400
300
200
200
300
200
100
100
-100
100
-100
1,500
-100
1,500
1,200
1,300
1,100
1,400
-100
1,200
1,200
1,300
1,500
1,700
1,949
2,167
1,036
1,045
940
2,982
2,358
4,057
1,494
341
0
411
380
353
317
334
374
323
403
398
252
231
271
404
313
253
533
318
199
244
347
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
5,000
0
5,000
5,000
5,000
5,483
5,236
5,000
5,000
5,032
5,408
5,499
5,451
5,549
4,449
4,664
4,893
3,236
3,345
3,454
3,570
3,688
3,812
3,939
4,071
4,172
4,313
3,448
2,445
480
0
409,169
452
419
582
613
718
568
586
41
26
11
288
553
464
218
220
209
202
187
175
162
149
136
123
108
93
213
203
194
184
18419420321393108123136149162175187202209220218464553288112641586568718613582419452409,16904802,4453,4484,3134,1724,0713,9393,8123,6883,5703,4543,3453,2364,8934,6644,4495,5495,4515,4995,4085,0325,0005,0005,2365,4835,0005,0005,00005,0005,0005,0005,0005,0005,0005,0005,0005,0005,0005,00034724419931853325331340427123125239840332337433431735338041103411,4944,0572,3582,9829401,0451,0362,1671,9491,7001,5001,3001,2001,200-1001,4001,1001,3001,2001,500-1001,500-100100-100100100200300200200300400600100300400100300200200200-100100-10010010010010010000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
32
408
454
451
549
1,512
1,627
1,756
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000000000000000000000000001,7561,6271,51254945145440832000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483
236
0
0
0
0
46
0
0
2,937
3,037
3,136
3,236
3,346
3,454
3,569
3,688
3,812
3,939
4,071
4,172
4,313
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000004,3134,1724,0713,9393,8123,6883,5693,4543,3463,2363,1363,0372,9370046000023648300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
483
236
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000000000000023648300000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
3,100
0
0
0
1,300
0
0
0
1,100
0
0
0
2,000
0
0
0
4,100
4,100
4,100
4,100
4,100
4,200
4,100
4,100
4,200
4,300
4,300
4,100
4,100
5,400
5,600
7,600
8,200
7,100
6,800
7,100
6,400
5,700
6,900
9,200
9,400
11,000
14,900
22,600
22,800
21,600
21,200
19,900
18,800
17,000
15,200
13,600
11,900
11,300
10,400
8,900
6,300
6,100
7,664
6,967
5,558
5,033
4,624
4,340
4,167
4,623
5,846
3,182
2,317
1,969
1,405
1,941
1,988
1,747
2,108
1,920
1,873
1,925
1,775
1,486
1,118
1,174
1,325
1,309
1,282
1,680
1,649
1,500
1,191
18,696
15,720
8,030
1,730
374
552
2,865
4,452
4,320
4,786
3,132
4,596
2,679
3,075
2,241
1,058
738
-339
-893
-1,194
-1,324
-1,446
-3,238
-3,321
-5,669
-4,846
150
4,010
8,258
6,990
5,998
5,054
3,591
2,560
1,718
987
-3,819
3,589
5,488
7,923
0
6,436
6,066
6,326
5,435
5,479
6,543
5,799
5,235
5,445
5,287
8,618
8,761
13,600
37,614
36,467
35,437
33,963
32,171
31,701
29,047
27,791
26,811
25,520
24,337
24,605
23,623
21,771
19,998
17,852
16,068
16,06817,85219,99821,77123,62324,60524,33725,52026,81127,79129,04731,70132,17133,96335,43736,46737,61413,6008,7618,6185,2875,4455,2355,7996,5435,4795,4356,3266,0666,43607,9235,4883,589-3,8199871,7182,5603,5915,0545,9986,9908,2584,010150-4,846-5,669-3,321-3,238-1,446-1,324-1,194-893-3397381,0582,2413,0752,6794,5963,1324,7864,3204,4522,8655523741,7308,03015,72018,6961,1911,5001,6491,6801,2821,3091,3251,1741,1181,4861,7751,9251,8731,9202,1081,7471,9881,9411,4051,9692,3173,1825,8464,6234,1674,3404,6245,0335,5586,9677,6646,1006,3008,90010,40011,30011,90013,60015,20017,00018,80019,90021,20021,60022,80022,60014,90011,0009,4009,2006,9005,7006,4007,1006,8007,1008,2007,6005,6005,4004,1004,1004,3004,3004,2004,1004,1004,2004,1004,1004,1004,1004,1000002,0000001,1000001,3000003,100
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
600
600
600
629
631
631
638
645
656
665
673
680
688
703
724
745
788
802
813
836
846
855
869
885
905
920
938
952
968
993
1,019
1,035
1,049
1,069
1,286
1,300
1,311
1,325
1,354
1,390
1,418
1,446
1,460
1,484
1,507
1,537
1,582
1,686
1,722
1,761
1,805
1,815
1,842
1,850
1,851
1,999
2,062
2,093
2,105
2,194
2,368
2,197
2,197
2,189
87
87
87
87
87
88
88
117
151
166
0
166
169
187
189
195
200
202
203
208
215
237
242
262
314
299
301
301
302
307
309
309
310
310
311
318
320
321
322
322
322
3223223223213203183113103103093093073023013012993142622422372152082032022001951891871691660166151117888887878787872,1892,1972,1972,3682,1942,1052,0932,0621,9991,8511,8501,8421,8151,8051,7611,7221,6861,5821,5371,5071,4841,4601,4461,4181,3901,3541,3251,3111,3001,2861,0691,0491,0351,0199939689529389209058858698558468368138027887457247036886806736656566456386316316296006006000000000000000000000000000000000000000000000000000000000
   Retained Earnings -246,724-243,934-240,750-237,867-234,590-231,451-228,196-225,506-222,995-220,707-218,385-214,909-212,163-208,619-204,790-200,777-196,443-194,044-191,836-189,612-187,050-184,410-181,817-179,730-177,590-175,052-170,170-164,868-159,391-158,0120-156,174-154,388-152,594-152,754-151,165-150,118-149,014-147,742-146,149-144,856-143,254-141,018-144,770-141,616-142,027-138,778-135,163-132,237-129,655-127,178-125,083-123,223-122,594-121,717-120,831-118,039-116,266-114,979-113,452-112,326-111,055-109,784-108,277-95,693-94,507-93,163-91,788-91,223-90,493-88,652-85,967-84,769-83,714-82,282-80,509-78,707-76,560-74,147-72,908-71,762-70,643-69,463-68,456-67,634-66,600-65,905-65,096-64,407-63,756-62,786-61,981-60,767-57,738-58,636-58,696-57,989-57,042-56,254-55,124-53,715-52,741-51,500-50,200-46,600-44,700-43,100-41,700-40,000-38,300-36,500-34,500-33,200-31,700-30,100-28,800-26,800-25,300-24,300-23,300-22,400-21,700-21,000-20,300-19,700-18,800-18,000-16,900-15,500-15,500-14,100-14,100-12,300-12,300-12,300-12,300-11,000-11,000-11,000-11,000-10,200-10,200-10,200-9,900000-8,800000-7,500000-6,100000-4,300
   Accumulated Other Comprehensive Income 
-100
0
0
0
-100
0
0
0
-200
0
0
0
-300
0
0
0
-400
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-500
-600
-600
-600
-600
-600
-600
-600
-600
-700
-700
-700
-700
-700
-800
-800
-900
-900
-1,000
-1,100
-1,100
-1,200
-1,300
-1,400
-1,400
-1,500
-1,600
-1,600
-1,700
-1,760
-1,776
-1,838
-1,838
-1,838
-1,838
-2,004
-2,004
-2,004
-2,004
-2,051
-2,051
-2,051
-2,051
-2,084
-2,084
-2,084
-2,084
-2,101
-2,101
-2,101
-2,101
-2,116
-2,116
-2,116
-2,116
-2,131
-2,131
-2,131
-2,131
-2,141
1,071
-2,079
-10,345
-17,155
-13,390
-12,986
-10,702
-2,162
158
776
-308
1,000
-211
-473
-789
-2,178
-105
-518
-779
-654
349
639
-1,113
-5,000
-211
-220
-46
-350
-2
-6
-10
-14
-17
-27
-39
-102
-57
-68
-79
-36
0
-40
-43
-48
-54
-60
-72
-87
-95
0
-124
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000-1240-95-87-72-60-54-48-43-400-36-79-68-57-102-39-27-17-14-10-6-2-350-46-220-211-5,000-1,113639349-654-779-518-105-2,178-789-473-2111,000-308776158-2,162-10,702-12,986-13,390-17,155-10,345-2,0791,071-2,141-2,131-2,131-2,131-2,131-2,116-2,116-2,116-2,116-2,101-2,101-2,101-2,101-2,084-2,084-2,084-2,084-2,051-2,051-2,051-2,051-2,004-2,004-2,004-2,004-1,838-1,838-1,838-1,838-1,776-1,760-1,700-1,600-1,600-1,500-1,400-1,400-1,300-1,200-1,100-1,100-1,000-900-900-800-800-700-700-700-700-700-600-600-600-600-600-600-600-600-500-500-500-500-500-500-500-500-500-500-500-500-500-400000-300000-200000-100000-100
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124,348
125,127
125,755
125,958
126,267
127,693
128,655
130,571
133,050
134,750
136,214
140,207
144,444
146,232
146,728
147,705
150,753
151,101
151,232
151,472
151,734
152,051
148,848
156,066
159,725
163,931
0
164,282
165,289
171,007
175,416
180,337
183,933
185,327
186,849
189,646
192,122
197,993
200,354
207,382
233,742
236,944
0
0
244,032
246,303
247,123
248,189
249,496
250,716
0
0
0
0
0
0
0
0000000250,716249,496248,189247,123246,303244,03200236,944233,742207,382200,354197,993192,122189,646186,849185,327183,933180,337175,416171,007165,289164,2820163,931159,725156,066148,848152,051151,734151,472151,232151,101150,753147,705146,728146,232144,444140,207136,214134,750133,050130,571128,655127,693126,267125,958125,755125,127124,3480000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
7,500
0
0
0
7,500
0
0
0
8,800
0
0
0
11,100
0
0
0
14,400
14,800
14,800
14,800
15,600
15,700
15,600
15,600
17,000
17,100
17,100
16,900
18,700
20,000
21,700
23,700
25,700
25,700
26,200
27,400
27,300
27,300
29,300
32,300
33,400
36,000
40,900
50,200
52,400
52,600
53,800
54,100
54,400
54,600
54,700
54,900
55,000
55,800
56,600
54,900
55,900
57,000
59,776
60,051
60,051
60,649
61,022
61,673
62,197
62,586
62,904
63,261
65,647
64,030
64,416
65,560
66,282
66,839
67,871
68,709
69,474
70,519
71,532
72,343
73,106
74,383
76,932
79,049
80,798
82,944
84,328
85,220
86,089
104,991
106,993
108,286
104,349
105,573
106,655
107,842
111,284
112,485
113,581
114,259
0
116,286
118,127
119,348
120,127
120,755
120,958
121,267
122,693
123,655
125,571
128,050
134,750
131,214
135,207
139,444
148,677
146,728
147,705
150,753
151,101
151,232
151,472
151,734
152,051
148,906
156,066
159,725
163,931
0
164,282
165,289
171,007
175,416
180,337
183,933
185,327
186,849
189,646
192,122
197,993
200,354
207,382
233,742
236,944
239,927
242,281
244,032
246,303
247,123
248,189
249,496
250,716
252,222
255,738
257,893
259,317
260,426
261,464
262,470
262,470261,464260,426259,317257,893255,738252,222250,716249,496248,189247,123246,303244,032242,281239,927236,944233,742207,382200,354197,993192,122189,646186,849185,327183,933180,337175,416171,007165,289164,2820163,931159,725156,066148,906152,051151,734151,472151,232151,101150,753147,705146,728148,677139,444135,207131,214134,750128,050125,571123,655122,693121,267120,958120,755120,127119,348118,127116,2860114,259113,581112,485111,284107,842106,655105,573104,349108,286106,993104,99186,08985,22084,32882,94480,79879,04976,93274,38373,10672,34371,53270,51969,47468,70967,87166,83966,28265,56064,41664,03065,64763,26162,90462,58662,19761,67361,02260,64960,05160,05159,77657,00055,90054,90056,60055,80055,00054,90054,70054,60054,40054,10053,80052,60052,40050,20040,90036,00033,40032,30029,30027,30027,30027,40026,20025,70025,70023,70021,70020,00018,70016,90017,10017,10017,00015,60015,60015,70015,60014,80014,80014,80014,40000011,1000008,8000007,5000007,500



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-10-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-13,831
Operating Income-13,831-13,831
 
Operating Expense (+$)
Research Development6,396
Selling General Administrative7,435
Selling And Marketing Expenses0
Operating Expense13,83113,831
 
Net Interest Income (+$)
Interest Income1,133
Interest Expense-0
Other Finance Cost-0
Net Interest Income1,133
 
Pretax Income (+$)
Operating Income-13,831
Net Interest Income1,133
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,554-15,108
EBIT - interestExpense = -12,698
-12,410
-12,554
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-12,698-12,554
Earnings Before Interest and Taxes (EBITDA)-12,661
 
After tax Income (+$)
Income Before Tax-12,554
Tax Provision-0
Net Income From Continuing Ops-12,698-12,554
Net Income-12,554
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,831
Total Other Income/Expenses Net1,277-1,133
 

Technical Analysis of Anixa
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Anixa. The general trend of Anixa is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Anixa's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Anixa Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Anixa Biosciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 3.15 < 3.8 < 4.0954.

The bearish price targets are: 2.46 > 2.46 > 2.331.

Know someone who trades $ANIX? Share this with them.πŸ‘‡

Anixa Biosciences Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Anixa Biosciences Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Anixa Biosciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Anixa Biosciences Inc. The current macd is 0.02855396.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Anixa price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Anixa. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Anixa price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Anixa Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartAnixa Biosciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Anixa Biosciences Inc. The current adx is 17.36.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Anixa shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Anixa Biosciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Anixa Biosciences Inc. The current sar is 3.49812377.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Anixa Biosciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Anixa Biosciences Inc. The current rsi is 48.32. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Anixa Biosciences Inc Daily Relative Strength Index (RSI) ChartAnixa Biosciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Anixa Biosciences Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Anixa price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Anixa Biosciences Inc Daily Stochastic Oscillator ChartAnixa Biosciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Anixa Biosciences Inc. The current cci is -101.4100804.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Anixa Biosciences Inc Daily Commodity Channel Index (CCI) ChartAnixa Biosciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Anixa Biosciences Inc. The current cmo is -13.62279837.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Anixa Biosciences Inc Daily Chande Momentum Oscillator (CMO) ChartAnixa Biosciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Anixa Biosciences Inc. The current willr is -84.44444444.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Anixa Biosciences Inc Daily Williams %R ChartAnixa Biosciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Anixa Biosciences Inc.

Anixa Biosciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Anixa Biosciences Inc. The current atr is 0.18545765.

Anixa Biosciences Inc Daily Average True Range (ATR) ChartAnixa Biosciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Anixa Biosciences Inc. The current obv is 2,369,995.

Anixa Biosciences Inc Daily On-Balance Volume (OBV) ChartAnixa Biosciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Anixa Biosciences Inc. The current mfi is 17.28.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Anixa Biosciences Inc Daily Money Flow Index (MFI) ChartAnixa Biosciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Anixa Biosciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-02-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-04-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-08STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-04-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-14STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-04-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-05-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-13MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-06-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2025-06-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Anixa Biosciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Anixa Biosciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5048.317
Ma 20Greater thanMa 503.338
Ma 50Greater thanMa 1002.981
Ma 100Greater thanMa 2002.920
OpenGreater thanClose3.120
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Anixa with someone you think should read this too:
  • Are you bullish or bearish on Anixa? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Anixa? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Anixa Biosciences Inc

I send you an email if I find something interesting about Anixa Biosciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Anixa Biosciences Inc.

Receive notifications about Anixa Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.